发明授权
US08853206B2 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
有权
作为PAR1抑制剂的三唑鎓盐，其制备和用作药物
- 专利标题： Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
- 专利标题（中）： 作为PAR1抑制剂的三唑鎓盐，其制备和用作药物
-
申请号： US13452146申请日： 2012-04-20
-
公开(公告)号： US08853206B2公开(公告)日： 2014-10-07
- 发明人: Uwe Heinelt , Volkmar Wehner , Matthias Herrmann , Karl Schoenafinger , Henning Steinhagen
- 申请人： Uwe Heinelt , Volkmar Wehner , Matthias Herrmann , Karl Schoenafinger , Henning Steinhagen
- 申请人地址： FR Paris
- 专利权人： Sanofi
- 当前专利权人： Sanofi
- 当前专利权人地址： FR Paris
- 优先权： EP08290114 20080205
- 主分类号： C07D249/00
- IPC分类号： C07D249/00 ; C07D413/06 ; C07D487/04 ; C07D471/04 ; A61P7/00
摘要：
The invention relates to novel compounds of formula I where X, A−, Q1, Q2, Q3, R2, R3, R4, R5, R6, R7, R8 and R9 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The invention further relates to a process for preparing the compound of formula I and to the use thereof as a medicament.
公开/授权文献
信息查询
